In-silico designing of NKK: A better ligand than Aciclovir against Herpes Simplex Virus

Neelabh ., K. K. Jeswara, A. Kumari, K. Singh

Abstract


Aciclovir is the best dr
thymidine kinase made by the HSV. In the current study we have successfully designed a drug candidate “NKK”, which is far more efficient than aciclovir in terms of binding energy and physiochemical properties again used softwares viz. Autodock 4.0, FireDock and Hex dock in order to demonstrate that “NKK” is a better ligand than aciclovir with respect to aforesaid properties.

Keywords


Aciclovir, Herpes Simplex Virus, in-silico, thymidine kinase

Full Text:

PDF


DOI: https://doi.org/10.30750/ijpbr.3.1.8

Refbacks

  • There are currently no refbacks.